Anika Tschirner - Concepedia

Author

Anika Tschirner

Charité - Universitätsmedizin Berlin

Also Known As

Anika Tschirner, Tschirner, Anika

Publications

885

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin MSB Medical School Berlin Istituti di Ricovero e Cura a Carattere Scientifico Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele University of East Anglia

About

Anika Tschirner is an author at Charité - Universitätsmedizin Berlin specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	198
2	Pharmacology	4	4	146
3	Natural Sciences	1	1	52
4	Cell Biology	1	1	52
5	Molecular Biology	1	1	52

Anika Tschirner

Publications

879

Citations

H-Index

Page 1

	Year	Citations
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure Jochen Springer, Anika Tschirner, Arash Haghikia, European Heart Journal	2013	203
Catabolic Signaling and Muscle Wasting After Acute Ischemic Stroke in Mice Jochen Springer, Susanne Schust, Katrin Peske, Stroke	2014	92
The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats Mareike S. Pötsch, Anika Tschirner, Sandra Palus, Journal of Cachexia Sarcopenia and Muscle	2013	69
Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation Vincenzo Musolino, Sandra Palus, Anika Tschirner, Journal of Cachexia Sarcopenia and Muscle	2016	59
Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia Jochen Springer, Anika Tschirner, Kai Hartman, International Journal of Cancer	2012	55
TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy Anna Baumgarten, Claudia Bang, Anika Tschirner, International Journal of Cardiology Cardiac MuscleCardiomyopathyMolecular PhysiologyHuman End-stageNatural Sciences	2013	52
Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia Sandra Palus, Stephan von Haehling, V FLACH, International Journal of Cardiology Cardiac FunctionHeart FailureCardiovascular DiseaseMedicinePhysiology	2013	52
Formoterol in the treatment of experimental cancer cachexia: effects on heart function Míriam Toledo, Jochen Springer, Sı́lvia Busquets, Journal of Cachexia Sarcopenia and Muscle	2014	49
Influence of cancer cachexia on drug liver metabolism and renal elimination in rats Katja Trobec, Mojca Kerec Kos, Jurij Trontelj, Journal of Cachexia Sarcopenia and Muscle	2015	38
The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy Jochen Springer, Anika Tschirner, Kai Hartman, International Journal of Cardiology CardiomyopathyMedicinePharmacotherapyCardiovascular ToxicityPharmacology	2013	38

Page 1